1. Introduction {#sec0005}
===============

Cerebral palsy (CP) is the most common pediatric-onset neurological disorder affecting movement. CP is caused by a nonprogressive brain injury or stroke before birth or during early life. People with unilateral spastic cerebral palsy (USCP), the most common subtype, have movement impairments primarily on one side of the body. Importantly, motor deficits can have profound, permanent consequences on quality of life and independence, particularly in adults. Few therapies exist for upper limb rehabilitation in adults with USCP. The goal of this pilot study was to determine feasibility and efficacy of combined upper limb robotic therapy and excitatory transcranial direct current stimulation (tDCS) for adults with USCP. Here we preset a case study of one participant. We examined changes in robotic task performance, clinical motor outcomes, and motor map neurophysiology after 36 sessions of tDCS plus upper limb robotic therapy.

Motor rehabilitation that follows the basic principles of motor learning appears to be optimal for recovery ([@ref011]). This requires repeated practice sessions that are sufficiently distributed to allow memory consolidation ([@ref003]), resulting in a higher state of functional performance. Robotic therapy is an effective method to facilitate this in chronic hemiparesis ([@ref031]). Robotic therapy devices can sense the amount of force a patient produces in a functional motor task and adjust the amount of assistance accordingly, such that an independently non-attainable functional goal is achieved ([@ref001]). There is mounting evidence that robotic therapy leads to a sustained positive effect on movement function in chronic stroke ([@ref019]). Movements trained in robotic therapy translate to functional outcome measures in patients with hemiparesis ([@ref002]).

TDCS modulates the excitability of a targeted brain region non-invasively by altering neuronal membrane potentials ([@ref022]). TDCS can prime brain motor circuits before robotic therapy. This innovative combination of two emerging technologies improves upper limb function in adult stroke survivors ([@ref008]; [@ref015]). Since USCP has a similar clinical presentation as hemiparetic stroke, we hypothesized that this therapy can also improve upper limb motor skill in adults with USCP.

A key difference between adult-onset stroke and pediatric-onset USCP is the organization of the motor system. In adult stroke, the contralateral wiring of the motor system has been established, but pediatric USCP disrupts motor system development. In as many as 30% of people with USCP, the contralesional hemisphere controls movement of both hands, controlling the impaired hand via ipsilateral connections ([@ref026]; [@ref027]). We have shown these ipsilateral connections to be adaptive and plastic ([@ref007]; [@ref025]). Since the wiring of the motor system is variable among people with USCP, in this study we used single-pulse transcranial magnetic stimulation (TMS) to first identify the locus of control of the impaired hand, then we targeted tDCS to stimulate this location. This personalized, targeted approach is hypothesized to optimize recovery for an individual.

2. Methods {#sec0010}
==========

The study participant was a 37 year old male who acquired USCP at age 18 months due to complications from a motor vehicle accident. The left side of his body is impaired. This study was approved by the Burke Rehabilitation Hospital Institutional Review Board. The participant provided written informed consent for all study procedures.

We conducted a battery of assessments: 1) Clinical outcome measures --the Wolf Motor Function Test, the Upper Limb Fugl-Meyer, and grip strength of the affected hand; 2) kinematic movement assessments on the robot; and 3) brain motor mapping with single-pulse transcranial magnetic stimulation (TMS). Assessments are described below.

2.1. Clinical outcome measures {#sec0015}
------------------------------

Clinical outcome measures were taken before the first day of the intervention, immediately after the final day of the intervention, and six months later. The Fugl-Meyer is a validated and reliable evaluation instrument used for measuring performance-based impairment in stroke patients ([@ref004]; [@ref009]; [@ref017]). The Wolf Motor Function Test assesses upper extremity function by asking the participant to complete 15 motor-based tasks and 2 strength-based tasks ([@ref018]). Grip strength was assessed using a Jamar hydraulic hand dynamometer (Lafayette Instrument, Lafayette, IN). The average of three trials was computed.

2.2. Upper limb robotic assessments and therapy {#sec0020}
-----------------------------------------------

We used In Motion Technology (IMT; Massachusetts Institute of Technology) planar and wrist robots in this study ([@ref032]). For both assessments and training, the participant sat in a foam-padded chair facing the robot and a video screen. The impaired arm was abducted, forearm supported, and hand lightly grasping the robot handle, and velcro straps lightly held the forearm and fingers secure. A cursor on the video screen displayed the targets and tracked the movement of the patient's upper limb.

2.3. Robotic evaluations {#sec0025}
------------------------

The participant performed unassisted movements toward targets presented in 8 positions equally spaced around a 14-cm radius circle ("star reaches") or around an ellipse with major axis corresponding to wrist flexion/extension of 22.5 degrees and minor axis corresponding to radial/ulnar deviation of 12.5 degrees ("circle drawing") ([@ref013]). Targets were presented in clockwise order similar to a robot-assisted therapy session (see below). A total of 80 movements of star reaches (done on both the planar and wrist robots) and 20 circle drawings (done only on the planar robot) were performed in each evaluation session.

Robotic evaluations (star reaches plus circle drawing) were done on each arm before the first day of the intervention, midway through the intervention, immediately after the final day of the intervention, and six months later. Additional circle drawing evaluations were done using the impaired arm at weeks 3, 5, and 10 of therapy. These were done to track transfer of skill from the trained task (star reaches) to an untrained task (circle drawing).

2.4. Robotic therapy {#sec0030}
--------------------

The participant received a total of 36 sessions comprising 1 hour of interactive robotic training, using the shoulder-elbow (planar) MIT Manus robot (30 mins), followed by the wrist robot (30 mins). The interactive robot features have been discussed at length elsewhere ([@ref013]) and involve visuomotor tasks, moving the robotic manipulandum according to targets on a computer screen mounted at eye level. A key feature of MIT robots is the low near isotropic inertia and reduced friction in the robot arm so that, when appropriate, it can "get out of the way." The force required to move the robotic arm is minimal, comparable to moving unrestricted, and if a patient cannot move the robot arm, it will guide the limb to provide an adaptive sensorimotor experience.

The participant alternated using the planar and wrist robots at each therapy session. Thus, the participant completed 18 training session on the planar robot and 18 sessions on the wrist robot. At the beginning of each session, the participant completed five rounds of target reaching without the assistance of the robot, followed by three blocks of 320 trials in which the robot assisted movement as needed. After each block, the participant completed five rounds of target reaching without the assistance of the robot. Thus, each session consisted of 64 unassisted reaches and 960 assisted reaches.

2.5. Robotic kinematic measures {#sec0035}
-------------------------------

We used a set of MATLAB programs (The Mathworks Inc., Waltham, MA) to extract measures of reach accuracy and movement smoothness (ratio of mean speed to peak speed) for each session. For star reaches, we measured the distance between the endpoint of the participant's reach and the location of the intended target. We also measured smoothness of reaching toward each target. We calculated overall reach error and smoothness, as well as reach error and smoothness in each reach direction.

For circle drawing, we measured circularity of drawn ellipses, the ratio of the length of the major axis to minor axis. For a perfectly round circle, circularity would equal 1.

2.6. TMS motor mapping {#sec0040}
----------------------

TMS motor mapping was done before the first day of the intervention and immediately after the final day of the intervention. Single-pulse TMS was conducted with a MagStim 200 and a 70 mm Figure-of-Eight stimulating coil (MagStim, Dyfed, United Kingdom). During TMS, muscle activity was recorded using surface electromyography (EMG) electrodes. A multi-channel recording system (NeuroConn, Germany) simultaneously recorded EMG activity bilaterally in the first dorsal interosseous (FDI) and extensor carpi radialis (ECR) muscles. These muscles were selected to yield a motor map with proximal and distal musculature.

The TMS device triggered the recording system, such that EMG activity was recorded at 4000 Hz 400 ms before and 400 ms after each TMS pulse is delivered. The position of each stimulation point over the scalp was recorded in xyz coordinates and overlaid on a standard MRI using neuronavigation software (Brainsight, Rogue Resolutions, Montreal, Canada).

To ensure all representations of the hand were found, stimulation began in a medial portion of the affected (right side) primary motor cortex (M1). The coil was moved laterally to search for a motor evoked potential (MEP) in the affected (left) FDI. In this participant, there was no MEP in the affected M1, which is common in people with USCP. We then stimulated the contralesional (left) M1, and found MEPs of both the left and right FDIs. We determined the resting motor threshold (rMT), which is the minimum stimulator output required to evoke an MEP over 50 μV in the FDI muscle in 6 of 10 trials in relaxed muscles ([@ref012]).

We superimposed a circular grid of 1 cm-spaced sites, radius 10 cm on the MRI (in Brainsight). The grid was centered around the point of strongest activation of the affected FDI ("hotspot"). The coil was used to deliver 2-3 TMS pulses at an intensity of 110% rMT at each grid point until MEPs were no longer found.

We processed MEP data by exporting EMG to MATLAB for filtering and processing in a custom-written analysis program. The MEP for each muscle at each stimulation site was defined as the peak-to-peak amplitude of the EMG response. Trials were excluded if the participant was not relaxed before the TMS pulse. MEPs will be averaged for stimuli delivered at the same site. If the average MEP is greater than 50 μV for a muscle at a site, that site was categorized as controlling that muscle. Total area enclosing digit and wrist sites for each hand was measured.

2.7. Colocalization of tDCS and motor map of affected hand {#sec0045}
----------------------------------------------------------

Before each therapy session, the participant received 20 min of 2 mA excitatory (anodal) tDCS (Soterix 1×1 Limited Total Energy device, New York, NY). We placed the excitatory sponge over the location of the motor map of the impaired hand, which was located with single-pulse TMS. The anodal sponge was placed on the contralateral forehead. Both sponges were moistened with saline and held in place with a headband. Before and after stimulation, we asked the participants to rate the presence of any symptoms related to tDCS (headache, tingling, itching).

2.8. Statistics {#sec0050}
---------------

For clinical outcomes and TMS measures, statistical differences could not be evaluated in this single-participant case study. For robotic kinematics, since many trials were done over the 36 days of training and four days of assessments, it was possible to examine statistical differences. We used repeated measures ANOVA with Bonferroni-corrected *post-hoc* comparisons to evaluate differences in kinematics over the intervention.

3. Results {#sec0055}
==========

In this pilot study, we found that combined tDCS and robotic upper limb therapy can safely improve upper limb function in adult USCP.

3.1. Improvements in clinical outcomes {#sec0060}
--------------------------------------

Clinical outcomes are summarized in [Table 1](#nre-41-nre1455-t001){ref-type="table"}. After the intervention, all measures improved. The Wolf improved 7.0 points, which is a clinically meaningful change, while the Fugl-Meyer improvements of 3.0 pointes neared a clinically meaningful change (Clinically meaningful change: Fugl-Meyer 4.25 points ([@ref021]), Wolf 4.36 points ([@ref016])). Improvements were maintained six months after intervention.

###### 

Changes in clinical outcome measures after therapy

  Outcome Measures            Before Therapy   After Therapy   Six Months After Therapy
  -------------------------- ---------------- --------------- --------------------------
  Wolf Motor Function Test          45              52                    52
  Fugl-Meyer Upper Limb             10              13                    13
  Grip Strength (kg)               9.5             10.4                  10.8

3.2. Improvements in kinematic measures {#sec0065}
---------------------------------------

We examined movement smoothness and reaching error of robotic assessments and training, since these outcomes have been most responsive to change and correlated with clinical outcomes ([@ref005]). [Figure 1](#nre-41-nre1455-g001){ref-type="fig"} shows representative example movement trials for the planar and wrist robot star reaches and planar robot circle drawing.

![Representative traces of movement trials on the planar robot star reach task (top panel), wrist robot star reach task (middle panel), and planar robot circle drawing task (botton panel).](nre-41-nre1455-g001){#nre-41-nre1455-g001}

Over the course of the intervention, there was no significant change in movement smoothness on the planar ([Fig. 2A](#nre-41-nre1455-g002){ref-type="fig"}) or wrist ([Fig. 2B](#nre-41-nre1455-g002){ref-type="fig"}) robot. In contrast, reaching accuracy on the planar ([Fig. 2C](#nre-41-nre1455-g002){ref-type="fig"}) and wrist ([Fig. 2D](#nre-41-nre1455-g002){ref-type="fig"}) robots improved significantly. During the first half of the intervention (pre to mid), there was a statistically significant decrease in reach error on the planar robot (F(3,126) = 34.6, *p* \< 0.0001) and on the wrist robot (F(3,126) = 55.0, *p* \< 0.0001). Beyond the midpoint of the intervention, there was no further improvement in reach error (*p* \> 0.05).

![Over the intervention, movement smoothness did not significantly change on the planar (A) or wrist (B) robots. Reach error on both the planar (C) and wrist (D) robots improved significantly from pre-intervention to the midpoint (week 6; ^\*^*p* \< 0.001). There was no further improvement in reach error after the intervention or at the six-month follow-up.](nre-41-nre1455-g002){#nre-41-nre1455-g002}

We noted that reach error may be different depending on the direction of reach. Therefore, we examined reach error in each of the eight task directions ([Figs. 3](#nre-41-nre1455-g003){ref-type="fig"} and [4](#nre-41-nre1455-g004){ref-type="fig"}). For the planar robotic task ([Fig. 3](#nre-41-nre1455-g003){ref-type="fig"}), reach error was significantly elevated in the top and right directions (F(3,16) \> 5.0, *p* \< 0.0001), indicating that the participant had most difficulty extending his left (impaired) arm. For the wrist robotic task ([Fig. 4](#nre-41-nre1455-g004){ref-type="fig"}), reach error was similar in all directions during the first half of the intervention (pre to mid, F(3,16) \> 5.0, *p* \< 0.0001).

![Directional differences in planar reach error over the intervention. Each bar graph summarized reach error in the direction at which the graph is located relative to the center. The largest reach errors were found in the directions that required the participant to extend his upper limb. Error rates significantly decreased during the first half of the intervention (^\*^*p* \< 0.01 compared to mid, post, and follow-up), and did not further improve during the second half of the intervention.](nre-41-nre1455-g003){#nre-41-nre1455-g003}

![Directional differences in wrist reach error over the intervention. Each bar graph summarized reach error in the direction at which the graph is located relative to the center. Reaching error in equal amounts were found in the first half of the intervention (^\*^*p* \< 0.01 compared to mid, post, and follow-up), and did not further improve during the second half of the intervention.](nre-41-nre1455-g004){#nre-41-nre1455-g004}

3.3. Performance on an untrained task {#sec0070}
-------------------------------------

Since the star reaching task was performed 1024 times per session (960 assisted trials plus 64 unassisted trials), we examined performance on circle drawing. Circle drawing was performed only 20 times every two weeks. [Figure 5](#nre-41-nre1455-g005){ref-type="fig"} shows improvements in circularity of the drawn ellipses over the intervention. Circularity improved over the first half of the intervention (F(3,16) \> 4.0, *p* \< 0.0001). Beyond the midpoint of the intervention, there was no further improvement in circularity (*p* \> 0.05).

![Circularity of ellipses drawn on the planar robot. Twenty trials were performed every two weeks. The goal was to draw a perfect circle, whose ratio of major and minor axes would equal 1 (dotted line). During the half of the intervention, circularity improved compared to baseline (^\*^*p* \< 0.001). No further significant improvements occurred during the second half of the intervention.](nre-41-nre1455-g005){#nre-41-nre1455-g005}

3.4. Changes in the motor map of the impaired hand {#sec0075}
--------------------------------------------------

Using single-pulse TMS, we examined the areal size and excitability (MEP size) of the motor map of the impaired hand. There was an increase in the area of the impaired FDI and ECR muscle motor map after therapy ([Table 2](#nre-41-nre1455-t002){ref-type="table"} and [Fig. 6](#nre-41-nre1455-g006){ref-type="fig"}) and six months later.

###### 

Changes in neurophysiological measures after therapy

  TMS Measures                   Before Therapy   After Therapy   Six Months After Therapy
  ----------------------------- ---------------- --------------- --------------------------
  FDI map size (cm^2^)                 27              34                    25
  FDI MEP amplitude (μV) (SD)     95.6 (53.4)     120.9 (64.5)         191.8 (110.6)
  ECR map size (cm^2^)                 19              25                    31
  ECR MEP amplitude (μV) (SD)     211.6 (54.8)    148.0 (66.3)          241.7 (48.7)

![Motor map of the participant's impaired FDI muscle. The heat map represents the amplitude of the MEP across locations of the map (blue = low amplitude, red = high amplitude). The FDI motor map increased in size and excitability after therapy.](nre-41-nre1455-g006){#nre-41-nre1455-g006}

3.5. Safety outcomes {#sec0080}
--------------------

There were no adverse events in this study. Mild skin tingling and itching were reported after tDCS, and mild muscle soreness was reported after some robotic therapy sessions, particularly wrist robot therapy.

4. Discussion {#sec0085}
=============

In this pilot study, we aimed to determine safety and efficacy of combined tDCS and upper limb robotic therapy in an adult with USCP. This pilot study will inform future similar studies. We found that our innovative combination of excitatory tDCS and robotics was safe and produced long-lasting, clinically meaningful improvements in upper limb function.

4.1. Efficacy of combined tDCS and robotic therapy {#sec0090}
--------------------------------------------------

The combination of tDCS and upper limb robotic therapy has been shown to improve motor outcomes in individuals with stroke ([@ref033]) and spinal cord injury ([@ref023]). Our findings indicate that this combination of technologies is also a feasible, effective intervention for adults with USCP. More work is needed to parse out the contributions of the tDCS and the robotic therapy to the recovery process, such that therapy can be provided in an optimal manner for each individual.

4.2. Dosing of therapy {#sec0095}
----------------------

We adopted our protocol from our work in stroke rehabilitation. We do not know if this dose and duration of therapy is ideal for people with USCP. Our findings in this participant indicate that he reached maximum accuracy on the robotic measures by the midpoint of the intervention period. Thus, for this individual, six weeks of therapy may have been sufficient to achieve optimal recovery. However, we do not know if the effects of therapy would have persisted for six months if the training period had been shorter. More work is needed to identify "stop signals" that indicate a participant has achieved their optimal improvements. The optimal dose is likely to vary among individuals, and a personalized approach is the ideal way to maximize each person's recovery. Indeed, Straudi et al. demonstrated that the efficacy of tDCS and upper limb robot-assisted therapy depended on the type of stroke and length of time since stroke, with individuals with chronic subcortical stroke showing better recovery than individuals with acute cortical stroke ([@ref028]). It is plausible that a longer duration of therapy may have boosted the recovery of individuals with acute corticalstroke.

4.3. Therapy drives cortical plasticity {#sec0100}
---------------------------------------

Although this single case cannot be over-interpreted, our findings indicate that brain stimulation and skillful use of the impaired upper limb expands the motor map in adult CP. This finding is consistent with a robust body of literature that demonstrates expansions in cortical maps after skillful, repetitive use of the impaired limb ([@ref007]; [@ref010]; [@ref014]; [@ref020]; [@ref024]).

4.4. Individualized targeting of tDCS stimulation {#sec0105}
-------------------------------------------------

Although the clinical symptoms of USCP and stroke are similar, there are some key differences between adult-onset stroke and pediatric-onset USCP that is important to understand when translating a successful stroke therapy to USCP. In adult-onset stroke, the motor system has already achieved its mature, crossed pattern. In adult stroke, the loss of a contralateral pathway and reliance on an ipsilateral motor pathway to control the paretic side is thought to be a marker of severity and poor prognosis ([@ref030]). However, in USCP, developmental injury derails normal motor development. As many as 30% of people with USCP control the paretic side via ipsilateral motor pathways from the less-affected motor cortex ([@ref026]; [@ref027]). We have shown that these ipsilateral pathways have the potential to be functional and adaptive ([@ref007]; [@ref025]).

Different studies have adopted different montages for tDCS application. In adult stroke, damage to one hemisphere causes downregulation of activity in that hemisphere and an imbalance in intracortical inhibition between the two hemispheres ([@ref029]). One commonly-used neuromodulation strategy in stroke is to suppress activity in the contralesional hemisphere, to decrease the inhibition of the ipsilesional hemisphere by the contralesional hemisphere ([@ref034]). However, as described above, in people with CP, developmental neuroplasticity often leads to reorganization of the motor system ([@ref006]). If the contralesional motor cortex controls movement of both upper limbs, suppression of activity in the contralesional hemisphere may not be of benefit. We propose a personalized approach: to target excitatory (anodal) tDCS to whichever hemisphere controls movement of the impaired upper limb. Importantly, in our pilot study, there was no decrement in skill of the less-impaired upper limb (data not shown), indicating that tDCS over the less-affected M1 did not interfere with motor control of the less-impaired upperlimb.

While our findings indicate that combined tDCS and robotic upper limb therapy was effective for improving motor function in an adult with CP, it is necessary to study a larger number of individuals. We posit that evaluating clinical outcomes, kinematic improvements, and neurophysiological effects of the intervention will poise us to best understand the factors that contribute to recovery, the optimal therapy schedule and dose, and the optimal brain stimulation parameters. There is an urgent need for more effective therapies for adults with CP, and we believe that combined tDCS and robotic therapy shows promise as a way to improve motor function and quality of life in adults with CP.
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